Xiaoting Shan

908 total citations · 2 hit papers
14 papers, 726 citations indexed

About

Xiaoting Shan is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Xiaoting Shan has authored 14 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Biomaterials and 4 papers in Biomedical Engineering. Recurrent topics in Xiaoting Shan's work include Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers) and RNA Interference and Gene Delivery (2 papers). Xiaoting Shan is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers) and RNA Interference and Gene Delivery (2 papers). Xiaoting Shan collaborates with scholars based in China, Norway and Saudi Arabia. Xiaoting Shan's co-authors include Yaping Li, Xiaowei Zeng, Lin Mei, Nansha Gao, Zimu Li, Xiang Gong, Zhiwen Zhang, Jingyuan Wen, Jie Li and Wenfeng Zeng and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Controlled Release.

In The Last Decade

Xiaoting Shan

14 papers receiving 719 citations

Hit Papers

Current approaches of nanomedicines in the market and var... 2022 2026 2023 2024 2022 2025 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current approaches of nanomedicines in the market and various stage of clinical translation
    2022 227 citations Xiaoting Shan, Xiang Gong et al. Acta Pharmaceutica Sinica B profile →
  2. Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
    2025 16 citations Ying Cai, Lingli Zhou et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoting Shan China 9 377 312 234 156 83 14 726
Félix Sauvage Belgium 20 395 1.0× 207 0.7× 409 1.7× 243 1.6× 49 0.6× 35 1.1k
Sarwar Hossen Bangladesh 6 379 1.0× 397 1.3× 241 1.0× 182 1.2× 29 0.3× 11 816
Luisa M. Russell United States 11 468 1.2× 474 1.5× 440 1.9× 116 0.7× 53 0.6× 14 984
Magali Noiray France 14 224 0.6× 282 0.9× 350 1.5× 128 0.8× 48 0.6× 30 869
Stéphanie Deshayes United States 11 263 0.7× 293 0.9× 317 1.4× 111 0.7× 41 0.5× 14 740
Valentina Francia Netherlands 10 199 0.5× 295 0.9× 392 1.7× 125 0.8× 59 0.7× 11 718
Mohamadreza Amin Netherlands 16 520 1.4× 583 1.9× 368 1.6× 117 0.8× 76 0.9× 23 987
Jacob D. Ramsey United States 12 246 0.7× 357 1.1× 240 1.0× 90 0.6× 53 0.6× 19 820
Flavio Dormont France 6 252 0.7× 414 1.3× 304 1.3× 99 0.6× 65 0.8× 10 757

Countries citing papers authored by Xiaoting Shan

Since Specialization
Citations

This map shows the geographic impact of Xiaoting Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Shan more than expected).

Fields of papers citing papers by Xiaoting Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoting Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Shan. The network helps show where Xiaoting Shan may publish in the future.

Co-authorship network of co-authors of Xiaoting Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoting Shan. A scholar is included among the top collaborators of Xiaoting Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoting Shan. Xiaoting Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Shan, Xiaoting, Ying Cai, Xujie Sun, et al.. (2025). Computer‐Aided Design of Self‐Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual‐Modulation Strategy. Advanced Healthcare Materials. 14(7). e2404261–e2404261. 3 indexed citations
2.
Cai, Ying, Lingli Zhou, Lei Zhao, et al.. (2025). Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer. Nature Communications. 16(1). 687–687. 16 indexed citations breakdown →
3.
Shan, Xiaoting, Ying Cai, Lingli Zhou, et al.. (2024). Rational strategies for improving the efficiency of design and discovery of nanomedicines. Nature Communications. 15(1). 9990–9990. 24 indexed citations
4.
Cai, Ying, Tiantian Xu, Junfan Chen, et al.. (2024). Conformation Influences Biological Fates of Peptide‐Based Nanofilaments by Modulating Protein Adsorption and Interfilament Entanglement. Advanced Materials. 37(3). e2409130–e2409130. 3 indexed citations
5.
Sun, Xujie, Xiaoting Shan, Ying Cai, et al.. (2024). 5‐Fluorouracil Loaded Prebiotic–Probiotic Liposomes Modulating Gut Microbiota for Improving Colorectal Cancer Chemotherapy. Advanced Healthcare Materials. 14(4). e2403587–e2403587. 5 indexed citations
6.
Zhou, Lei, Zehong Zhang, Xiaoting Shan, et al.. (2023). STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy. National Science Review. 10(10). nwad214–nwad214. 30 indexed citations
7.
Cai, Ying, Xiaoting Shan, Lingli Zhou, et al.. (2023). Inhibiting Endothelial Cell‐Mediated T Lymphocyte Apoptosis with Integrin‐Targeting Peptide‐Drug Conjugate Filaments for Chemoimmunotherapy of Triple‐Negative Breast Cancer. Advanced Materials. 36(3). e2306676–e2306676. 12 indexed citations
8.
Shan, Xiaoting, Xiang Gong, Jie Li, et al.. (2022). Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica B. 12(7). 3028–3048. 227 indexed citations breakdown →
9.
Li, Zimu, Yao Yang, Xiaoting Shan, et al.. (2021). Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy. Journal of Controlled Release. 338. 719–730. 173 indexed citations
10.
Shan, Xiaoting, Bo Li, Fazhan Zhao, et al.. (2021). Radiation effects of heavy ions on the static and dynamic characteristics of 850 nm high-speed vertical cavity surface emitting lasers. Journal of Luminescence. 237. 118136–118136. 3 indexed citations
11.
Wang, Lei, Xuewen Zhang, Bo Li, et al.. (2021). Engineering and Microscopic Mechanism of Quantum Emitters Induced by Heavy Ions in hBN. ACS Photonics. 8(10). 2912–2922. 20 indexed citations
12.
Zhao, Lu, Weihe Zhong, Hsin‐Yi Chen, et al.. (2020). Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms. Biomedicine & Pharmacotherapy. 129. 110360–110360. 16 indexed citations
13.
Li, Zimu, Xiaoting Shan, Zhidong Chen, et al.. (2020). Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration. Advanced Science. 8(1). 2002589–2002589. 190 indexed citations
14.
Wang, Lei, Ningyang Liu, Bo Li, et al.. (2020). Comparison of X-Ray and Proton Irradiation Effects on the Characteristics of InGaN/GaN Multiple Quantum Wells Light-Emitting Diodes. IEEE Transactions on Nuclear Science. 67(7). 1345–1350. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Félix Sauvage Breakdown of academic impact, for papers by Sarwar Hossen Breakdown of academic impact, for papers by Luisa M. Russell Breakdown of academic impact, for papers by Magali Noiray Breakdown of academic impact, for papers by Stéphanie Deshayes Breakdown of academic impact, for papers by Valentina Francia Breakdown of academic impact, for papers by Mohamadreza Amin Breakdown of academic impact, for papers by Jacob D. Ramsey Breakdown of academic impact, for papers by Flavio Dormont
Rankless by CCL
2026